'Supplemental figure 3' diaporamas de présentation

Supplemental figure 3 - PowerPoint PPT Presentation


Supplemental Figure 3

Supplemental Figure 3

Supplemental Figure 3. B. A. NS. NS. control -shRNA. TLR2 -shRNA. control -shRNA. TLR2 -shRNA. MDS-A (low-risk). MDS-B (high-risk).

By lois
(64 views)

0.5

0.5

Supplemental Figure 3. Ngn3. HES1. Hexokinase 2. 4. 2.5. 8. 2. 3. 6. 1.5. 4. 2. 1. 2. 1. 0.5. 0. 0. 0. Ngn3-EGFP +. Ngn3-EGFP -. Ngn3-EGFP +. Ngn3-EGFP -. Ngn3-EGFP +. Ngn3-EGFP -. Insulin I. Pdx-1. MafA. 15. 2. 3. 1.5. 10. 2. 1. 5. 1. 0.5. 0. 0. 0.

By shing
(110 views)

CAMA-1

CAMA-1

A. Supplemental Figure 1. Cyclin E. Actin. B. 10A. 76NF2V. T47D. M4A4. 76N. 76NE7. ZR75-1. MCF-7. HCC38. NM2C5. HCC-1500. MDA-MB-453 (HER2+). Full Length Cyclin E Levels. LMW-E Levels. p=0.003. Cyclin E. Actin. Densitometry Units. HCC-1937. HCC-1954. HCC-1428.

By diem
(181 views)

Supplemental Figure 3

Supplemental Figure 3

Leucine kinetics ( m mol.kg -1 .h -1 ). Leucine kinetics ( m mol.kg -1 .h -1 ). 160. 160. NS. NS. 140. 140. NS. NS. 120. 120. 100. 100. 80. 80. 60. 60. NS. **. 40. 40. 20. 20. 0. 0. Ra LEU. Ox LEU. NOLD. Ra LEU. Ox LEU. NOLD. Supplemental Figure 3.

By emilia
(81 views)

- + - + - + - + (AvrBsT)

- + - + - + - + (AvrBsT)

At4g22285 At4g22290 At4g22300 At4g22310. - + - + - + - + (AvrBsT).

By lecea
(95 views)

Warfarin : - + + Quercetin : - - +

Warfarin : - + + Quercetin : - - +

Supplemental Figure 3. A. B. *. *. **. *. **. **. **. *. *. *. *. Warfarin : - + + Quercetin : - - +. Warfarin : - + + Quercetin : - - +. C. Warfarin : - + + - + + - + + Quercetin : - - + - - + - - +.

By dee
(206 views)

AL4

AL4

A. B. Supplimental figure 1. Melanoma free survival curve (A) and summary table (B) for median survival and melanoma free survival for each genotype. All of them are Ink/Arf-/-. C. A. B. EV. Sh4. Sh11. PTEN. AL4. ECAD. NCAD. pAKT. pERK. EV. Sh4. Sh11. -. pFAK. Pten. pSTAT.

By piera
(210 views)

0.01

0.01

Supplemental figure 3. 0.02 0.01 0 -0.01 -0.02. 0.03 0.02 0.01 0 -0.01 -0.02. 0.02 0.01 0 -0.01 -0.02. 0.02 0.01 0 -0.01 -0.02. 0.02 0.01 0 -0.01 -0.02. 0.02 0.01 0 -0.01 -0.02. 0.02 0 -0.02 -0.04. 0.02 0.01 0 -0.01 -0.02.

By zyta
(92 views)

Supplemental Figure 3

Supplemental Figure 3

wt apaf-1 -/- p53 -/-. Bcl-2. ERK2. C 16 24 48 C 16 24 48 C 16 24 48. TPT (h). Supplemental Figure 3.

By dima
(76 views)

Supplemental Figure 1

Supplemental Figure 1

Supplemental Figure 1. Events. Events. Events. Events. HLA-A2. CD137L. CD64. HLA-DR15. K562. Events. Events. aAPC. CD80. CD83. Supplemental Figure 2. CD3. FSC-H. FSC-A. CD14 , CD19, Vivid. SSC. CD4. CD8. FSC-A. Supplemental Figure 3. B. A. Fold expansion.

By leia
(145 views)

10 h

10 h

Supplemental Figure 1. 5 h. 10 h. 0 h. Untreated. 16 h. 14 h. 24 h.

By shauna
(135 views)

Supplemental Figure:3

Supplemental Figure:3

ATF6 α -N. α - tubulin. hATF6 α -Luc. D. Supplemental Figure:3. Fold change. -. C. ERR γ. +. +. +. -. -. PGC1 α. **. A. B. **. **. Human 2077 ggg aggtca agc 2066. Ad-GFP. **. Relative ATF6 α mRNA level. Human 1612 gat aggtca caa 1601. Ad- shUS. Ad-GFP. Ad- shERR γ.

By granville-hamon
(67 views)

Supplemental Figure 3

Supplemental Figure 3

Supplemental Figure 3. Control. Inhibitor treated. SNK6. NKYS. KAI3. SubG1. G2/M= 48.47%. G2/M= 72.58%. G2/M= 47.39%. G1. S. SubG1. G2/M. Fold changes in SubG1 (Control=1). Fold changes in G2/M (Control=1). SNK6. KAI3. SNK6. NKYS. KAI3. NKYS.

By cheyenne-hicks
(42 views)

Supplemental Figure 3, Ghielmetti et al

Supplemental Figure 3, Ghielmetti et al

medium. TB40/E. TB40/E-UV. Supplemental Figure 3, Ghielmetti et al.

By raymond-dickson
(82 views)

Supplemental Figure 1

Supplemental Figure 1

Supplemental Figure 1. A B. C. Supplemental Figure 2. RWPE-1. DU-145. AR- CaP -M. PC-3. AR- CaP -E. PC-3-ML. 70 kDa. c- myc. 57 kDa. β-actin. 42 kDa. Supplemental Figure 3. A B. Supplemental Figure 4. pPEG -Luc. pAEG -Luc. 24h 48h.

By fatima-york
(114 views)

Antagonist (n=2,855)

Antagonist (n=2,855)

Supplemental Figure 1: Serum P levels on day of hCG: Agonist vs antagonist. 0.75 ± 0.66. 0.84 ± 0.67. p=0.0003. Antagonist (n=2,855). Agonist (n=1,117). Age (years). Supplemental Figure 2. Ongoing pregnancy rate according to age and progesterone levels.

By fatima-cherry
(118 views)

SUPPLEMENTAL FIGURE 3

SUPPLEMENTAL FIGURE 3

SUPPLEMENTAL FIGURE 3. B. A. C. D.

By macey-nunez
(43 views)

Supplemental Figure 3

Supplemental Figure 3

Supplemental Figure 3.

By nathaniel-angelo
(57 views)

Supplemental Figure 3

Supplemental Figure 3

Supplemental Figure 3.

By galena-horne
(43 views)

Supplemental Figure 3

Supplemental Figure 3

Supplemental Figure 3. Test Set Molcules. ddb. Hydrastinine. + b hydrastine. Olopatadine. Olopatadine M1. KCNQ2. Roxithromycin. Roxithromycin M1. Roxithromycin M2. Roxithromycin M3.

By zenia-chan
(65 views)

View Supplemental figure 3 PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Supplemental figure 3 PowerPoint presentations. You can view or download Supplemental figure 3 presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.